In November 2017, we participated in the United Nations Global Compact (U...
ONO PHARMA KOREA has been supporting the childhood cancer NGO "Hanbit L...
We donate toothbrushes/toothpastes produced by our sub...
Environmental Costs (Including Depreciation Costs) (Thousands o...
Sustainability information We have received independent assurance so a...
Efforts made to promote employees’ health Organizational structure to ...
At Fujiyama Plant, our employees periodically clean the area su...
DE&I Initiatives (Promotion of diverse human resources) Other Init...
Targets Progress Initiatives Initiatives for Pharmaceuticals Ext...
There are considered to be approximately 250,000 children under...
Support for Disease Prevention, Early Detection and Early Treatment ...
We agree with the purport of the "Council on Promoting Partnership Buildi...
We provide training for all employees involved in promotion activities to...
Please refer to the “Corporate Governance Report” below for details on ou...
At Ono Pharmaceutical, the Board of Directors oversees important manageme...
Risks and opportunities related to climate change are investigated under ...
Since FY2014, ONO has been a constant supporting member of a public i...
Information Disclosure IR Activities ESG Activities
In September 2023, ONO joined PSCI (Pharmaceutical Supply Chain In...
Basic Policy for Human Rights Human Rights Due Diligence Access to R...
